4.6 Review

Targeting the GRP78 Pathway for Cancer Therapy

期刊

FRONTIERS IN MEDICINE
卷 7, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2020.00351

关键词

GRP78; endoplasmic reticulum stress; autophagy; apoptosis; tumor-targeted therapy

资金

  1. National Natural Science Foundation of China [81541153]
  2. Guangdong Science and Technology Department [2016A050503046, 2015A050502048, 2019B090905011]
  3. Southern Marine Science and Engineering Guangdong Laboratory Zhanjiang [ZJW-2019-07]
  4. Public Service Platform of South China Sea for R&D Marine Biomedicine Resources [GDMUK201808]

向作者/读者索取更多资源

The 78-kDa glucose-regulated protein (GRP78) plays an important part in maintaining protein stability, regulating protein folding, and inducing apoptosis autophagy, which is considered as a powerful protein. Meanwhile, it also plays a role in ensuring the normal function of organs. In recent years, more and more researches have been carried out on the targeted therapy of GRP78, mainly focusing on its relevant role in tumor and its role as a major modulator and modulator of subordinate pathways. The ability of GRP78 to respond to endoplasmic reticulum stress (ERS) determines whether tumor cells survive and whether the changes in expression level of GRP78 regulated by endoplasmic reticulum (ER) caused by various factors will directly or indirectly affect cell proliferation, apoptosis, and injury, or reduce the body's defense ability, or have protective effects on various organs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据